FILORIZZO, Clarissa
 Distribuzione geografica
Continente #
NA - Nord America 479
EU - Europa 142
AS - Asia 24
SA - Sud America 3
AF - Africa 1
Totale 649
Nazione #
US - Stati Uniti d'America 478
IT - Italia 68
DE - Germania 20
GB - Regno Unito 19
SG - Singapore 13
FI - Finlandia 7
IE - Irlanda 7
IN - India 6
BE - Belgio 4
RO - Romania 4
CN - Cina 3
SE - Svezia 3
CL - Cile 2
RU - Federazione Russa 2
UA - Ucraina 2
AL - Albania 1
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
NO - Norvegia 1
Totale 649
Città #
Chandler 88
Ashburn 74
Fairfield 51
Woodbridge 33
Houston 24
Wilmington 21
New York 18
Medford 17
Cambridge 14
Seattle 13
Ann Arbor 12
Des Moines 11
Palermo 11
Lawrence 10
Princeton 10
San Diego 10
Altamura 9
Ludwigshafen am Rhein 8
Dublin 6
Milan 6
Helsinki 5
Rome 5
Singapore 5
Bremen 4
Brussels 4
London 4
Padova 4
Kilburn 3
Kitzingen 3
Beijing 2
Boardman 2
Coimbatore 2
Council Bluffs 2
Falls Church 2
Foggia 2
Hounslow 2
Kiev 2
Los Angeles 2
Pune 2
Venice 2
Abidjan 1
Acton 1
Athlone 1
Aversa 1
Buffalo 1
Castelbuono 1
Cedar Knolls 1
Chicago 1
Chieti 1
Chiswick 1
Conegliano 1
Copenhagen 1
Edinburgh 1
Guangzhou 1
Göttingen 1
Hanover 1
Kumar 1
La Canada Flintridge 1
Lappeenranta 1
Manchester 1
Mehlingen 1
Moscow 1
New Bedfont 1
Nottingham 1
Oslo 1
Ottawa 1
Phoenix 1
Quito 1
Redwood City 1
San Francisco 1
San Paolo di Civitate 1
Southwark 1
Tappahannock 1
Tirana 1
Verona 1
Vienna 1
Washington 1
Zaragoza 1
Zurich 1
Totale 544
Nome #
Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine 120
A semi-automatic approach for epicardial adipose tissue segmentation and quantification on cardiac CT scans 109
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 97
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 89
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 58
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 48
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 45
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 44
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 33
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology 28
Epicardial Adipose Tissue Changes during Statin Administration in Relation to the Body Mass Index: A Longitudinal Cardiac CT Study 20
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 16
Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices 13
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 13
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 9
Totale 742
Categoria #
all - tutte 4.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 7 4 4 2 2 2
2020/2021171 7 6 4 4 46 7 20 7 14 20 10 26
2021/2022130 8 10 1 1 19 4 3 13 9 12 26 24
2022/2023211 19 41 8 28 25 26 10 20 16 5 10 3
2023/2024207 9 11 17 19 5 58 25 21 1 14 5 22
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 742